Advertisement
Advertisement

LEGN

LEGN logo

Legend Biotech Corporation - ADR

27.11
USD
Sponsored
-0.27
-0.97%
Jul 10, 14:50 UTC -4
Open

LEGN Earnings Reports

Positive Surprise Ratio

LEGN beat 9 of 22 last estimates.

41%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$366.88M
/
$0.08
Implied change from Q1 26 (Revenue/ EPS)
+20.25%
/
-126.67%
Implied change from Q2 25 (Revenue/ EPS)
+43.84%
/
-111.76%

Legend Biotech Corporation - ADR earnings per share and revenue

On May 12, 2026, LEGN reported earnings of -0.30 USD per share (EPS) for Q1 26, missing the estimate of -0.02 USD, resulting in a -1295.35% surprise. Revenue reached 305.10 million, compared to an expected 313.18 million, with a -2.58% difference. The market reacted with a +10.48% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 366.88 million USD, implying an decrease of -126.67% EPS, and increase of 20.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Legend Biotech Corporation - ADR reported EPS of -$0.30, missing estimates by -1295.35%, and revenue of $305.10M, -2.58% below expectations.
The stock price moved up 10.48%, changed from $25.58 before the earnings release to $28.26 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 7 analysts, Legend Biotech Corporation - ADR is expected to report EPS of $0.08 and revenue of $366.88M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement